Valerie Calvert - Concepedia

Author

Valerie Calvert

Also Known As

Calvert, Valerie, Emanuel Petricoin, V Calvert, V S Calvert, V. Calvert, V.S. Calvert, Valerie Calvert, Valerie S Calvert, Valerie S. Calvert, Victoria Calvert

279

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

George Mason University Center for Biologics Evaluation and Research National Cancer Institute University of Padua United States Food and Drug Administration

About

Valerie Calvert is an author at George Mason University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	1.8K
2	Health Sciences	3	3	88
3	Natural Sciences	3	3	260
4	Engineering	2	2	76
5	Social Sciences	1	1	20

Valerie Calvert

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Laser-capture microdissection Virginia Espina, Julia Wulfkuhle, Valerie Calvert, Nature Protocols	2006	828
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment Puneeth Iyengar, Virginia Espina, Terence W. Williams, Journal of Clinical Investigation	2005	411
Evaluation of Non-Formalin Tissue Fixation for Molecular Profiling Studies John W. Gillespie, Carolyn J.M. Best, Verena E. Bichsel, American Journal Of Pathology Non-formalin Tissue FixationMedicineHistopathologyPathologyMolecular Pathology	2002	284
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cloud P. Paweletz, David K. Ornstein, Mark J. Roth, PubMed Annexin 1Esophageal CancerLaser CapturePathologyCancer Biology	2000	229
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays Julia Wulfkuhle, Joy Aquino, Valerie Calvert, PROTEOMICS	2003	221
Signal pathway profiling of prostate cancer using reverse phase protein arrays Robert L. Grubb, Valerie Calvert, Julia D. Wulkuhle, PROTEOMICS Signal Pathway ProfilingSignal RecognitionMolecular BiologyLaser Capture MicrodissectionCancer Biology	2003	194
Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial Daniela Matei, Michael W. Sill, Heather A. Lankes, Journal of Clinical Oncology Malignant DiseaseMedicinePharmacologyGynecologyPathology	2010	175
Mitochondrial proteome: Altered cytochrome <b> <i>c</i> </b> oxidase subunit levels in prostate cancer Paul C. Herrmann, John W. Gillespie, Lu Charboneau, PROTEOMICS	2003	151
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp, Cancer Research	2022	144
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols Linda Zuurbier, Irene Homminga, Valerie Calvert, Leukemia Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaImmunology	2010	140

Page 1